Dianthus Therapeutics (DNTH) files $600M mixed shelf
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/1/2026
- Wall St kicks off September under pressure as higher yields, oil prices weigh
- Oil prices rise 2% as US-Iran fighting stokes supply fears
- Two Saudi tankers struck in Strait of Hormuz Monday
- Fed’s Barr backs rate hike if inflation fails to cool, September odds hit 66%
- The Warsh pivot markets didn't expect
This biotech stock is a Top Pick for 2026 at Oppenheimer
January 30, 2026 2:00 PM ESTOne biotech company is drawing attention from analysts at Jefferies, which highlighted its pipeline momentum and raised its price target to $125 from $62, calling the stock a top pick ahead of 2026 catalysts, in a note to clients this week.
Jefferies noted that Dianthus Therapeutics (NASDAQ: DNTH) shares have already climbed 22 percent this year, outpacing the XBIs 5 percent gain,... More
